MoonLake Immunotherapeutics (NASDAQ: MLTX)

Biotechnology Research • Zug, Zug, Switzerland • 101-200 Employees

Company overview

Headquarters	Dorfstrasse, 29, Zug, Zug 6300, CH
Phone number	+41415108022
Website	moonlaketx.com
NAICS	541714
Keywords	Partnering, Immunotherapy, Inflammatory Skin & Joint Diseases, Il17A / F, #HS, #Il17, #Mltx, #Nanobody, #Psa
Founded	2021
Employees	101-200
Socials

Key Contact at MoonLake Immunotherapeutics (NASDAQ: MLTX)

Jorge Santos Da Silva

Founder & Chief Executive Officer

Mobile @moonlaketx.com

MoonLake Immunotherapeutics (NASDAQ: MLTX) Email Formats

MoonLake Immunotherapeutics (NASDAQ: MLTX) uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@moonlaketx.com), used 51.8% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@moonlaketx.com	51.8%
{first initial}.{last name}	j.doe@moonlaketx.com	47.4%

About MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

MoonLake Immunotherapeutics (NASDAQ: MLTX) revenue & valuation

Annual revenue	$12,100,000
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$38,700,000
Total funding	$475,000,000

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Manager

Director

Entry

Employees by Department

MoonLake Immunotherapeutics (NASDAQ: MLTX) has 63 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore MoonLake Immunotherapeutics (NASDAQ: MLTX)'s funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-28	14	$400,000,000
2025-05-03	16	$75,000,000

Funding Insights

$475,000,000

Total funding amount

$75,000,000

Most recent funding amount

Number of funding rounds

MoonLake Immunotherapeutics (NASDAQ: MLTX) Tech Stack

Discover the technologies and tools that power MoonLake Immunotherapeutics (NASDAQ: MLTX)'s digital infrastructure, from frameworks to analytics platforms.

Vimeo

Video players

WP Rocket

Caching

Twenty Twenty

WordPress themes

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

Frequently asked questions

MoonLake Immunotherapeutics (NASDAQ: MLTX) is located in Zug, Zug, CH.

You can reach MoonLake Immunotherapeutics (NASDAQ: MLTX) at +41415108022.

MoonLake Immunotherapeutics (NASDAQ: MLTX) was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

MoonLake Immunotherapeutics (NASDAQ: MLTX) has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

MoonLake Immunotherapeutics (NASDAQ: MLTX) has raised a total of $475,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at MoonLake Immunotherapeutics (NASDAQ: MLTX)

Jorge Santos Da Silva

Founder & Chief Executive Officer

Mobile @moonlaketx.com

4.8

40,000 users